DCF — MILTON S. HERSHEY MEDICAL CENTER
Enterprise Value: $-1.2B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-1.2B
Enterprise Value
$-421.7M
PV of Cash Flows
$-762.6M
PV of Terminal Value
$-1.2B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $2.1B | $-48.1M | -2.0% | $-138.6M | $-126.0M |
| Year 2 | $2.2B | $-27.6M | -1.0% | $-120.8M | $-99.8M |
| Year 3 | $2.3B | $-5.7M | -0.0% | $-101.7M | $-76.4M |
| Year 4 | $2.3B | $5.8M | 0.0% | $-93.1M | $-63.6M |
| Year 5 | $2.4B | $12.0M | 0.0% | $-89.9M | $-55.8M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-1.2B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$2.1B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.02751306907873096
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5